Upon further heating, phase 6I transforms to a new anhydrous polymorph 6II, which transforms upon cooling to a further new phase 6III. Thermogravimetric measurements performed in tandem with differential scanning calorimetry as well as infrared spectroscopic investigations are in agreement with these findings. The de/resolvation behavior is accompanied by a dramatic change in their magnetic properties: The dihydrate see more phase shows antiferromagnetic exchange interactions, whereas ferromagnetic properties are observed for the trimorphic anhydrate system. This magnetic sponge-like behavior can be reversibly
cycled upon de/resolvation of the material.”
“Adsorption of synthetic flue gas on a commercial zeolite 13X (APGIIA) with targeted Si/Al ratio has been studied aiming to design
an adsorption process for CO2 capture from post-combustion power plants. Adsorption equilibrium of pure gases (CO2 and N2) has been measured in a wide range of temperatures: 303, 333, 363, 393, 423, 473 K. Adsorption equilibrium was fitted with the multisite Langmuir model. The adsorption capacity of the zeolite pellets for CO2 is 4.54 mol/kg and 0.26 mol/kg for N2 at 303 K and 100 kPa. The dynamic behavior of the pellets in a fixed bed was also studied PD-1/PD-L1 Inhibitor 3 in vivo by measuring breakthrough curves. Adsorption and desorption was analyzed in order to understand the regeneration of the adsorbent. Based on equilibrium and kinetic data, two different
adsorption technologies were simulated: Vacuum Pressure Swing Adsorption (VPSA) and Temperature Swing Adsorption (TSA). A CO2 recovery of 63.0% with 72.1% purity was obtained using a five-step PD-1/PD-L1 Inhibitor 3 cell line PSA cycle included rinse step. In a 5-step TSA process, however, a CO2 purity of 78.7% and recovery of 76.6% can be achieved under a heating temperature of 423 K.”
“Background: Clinicians and patients find prognosis and end-of-life care discussions challenging. Misunderstanding one’s prognosis can contribute to poor decision-making and end-of-life quality of life. A question prompt list (booklet of questions patients can ask clinicians) targeting these issues may help overcome communication barriers. None exists for end-of-life discussions outside the palliative care setting.\n\nAim: To develop/pilot a question prompt list facilitating discussion/planning of end-of-life care for oncology patients with advanced cancer from Australia and the United States and to explore acceptability, perceived benefits/challenges of using the question prompt list, suggestions for improvements and the necessity of country-specific adaptations.\n\nDesign: An expert panel developed a question prompt list targeting prognosis and end-of-life issues. Australian/US semi-structured interviews and one focus group elicited feedback about the question prompt list. Transcribed data were analysed using qualitative methods.